Pralatrexate Injection
Product Images NDC 43598-342

This text provides detailed information about a pharmaceutical product called Pralatrexate. It includes instructions for dosage, administration, storage, and manufacturer details. The product contains 20 mg of Pralatrexate in 1 mL of sterile solution and is intended for intravenous use as a cytotoxic agent. The text emphasizes single-dose use and specific administration guidelines such as intravenous push over 3-5 minutes. It also mentions the inclusion of sodium chloride and pH adjustment agents in the product formulation. The product is manufactured by Dr. Reddy's Laboratories Inc. in India. It provides a ML number, code number, and GTIN for identification purposes. Storage instructions recommend refrigeration at 2°C to 8°C and protection from light. The text further suggests not diluting the solution, and the recommended expiration date is 08/2025.*

This text seems to describe a medicinal product containing pralatrexate in a 2mL vial, with a concentration of 40mg. The medication is for intravenous use as a cytotoxic agent and should be administered as a single dose over 3-5 minutes. It is advised to store the vial in its carton, protect it from light, and refrigerate at 2°C to 8°C. The recommended dosage information is available in the accompanying package insert.*